IBDEI090 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12003,1,4,0)
 ;;=4^SINUSITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,12003,2)
 ;;=^269865
 ;;^UTILITY(U,$J,358.3,12004,0)
 ;;=473.8^^71^728^21
 ;;^UTILITY(U,$J,358.3,12004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12004,1,3,0)
 ;;=3^473.8
 ;;^UTILITY(U,$J,358.3,12004,1,4,0)
 ;;=4^SINUSITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,12004,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,12005,0)
 ;;=463.^^71^728^22
 ;;^UTILITY(U,$J,358.3,12005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12005,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,12005,1,4,0)
 ;;=4^TONSILLITIS
 ;;^UTILITY(U,$J,358.3,12005,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,12006,0)
 ;;=011.90^^71^728^23
 ;;^UTILITY(U,$J,358.3,12006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12006,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,12006,1,4,0)
 ;;=4^TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,12006,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,12007,0)
 ;;=465.9^^71^728^24
 ;;^UTILITY(U,$J,358.3,12007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12007,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,12007,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,12007,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,12008,0)
 ;;=599.0^^71^728^25
 ;;^UTILITY(U,$J,358.3,12008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12008,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,12008,1,4,0)
 ;;=4^UTI
 ;;^UTILITY(U,$J,358.3,12008,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,12009,0)
 ;;=616.10^^71^728^26
 ;;^UTILITY(U,$J,358.3,12009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12009,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,12009,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,12009,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,12010,0)
 ;;=277.30^^71^729^1
 ;;^UTILITY(U,$J,358.3,12010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12010,1,3,0)
 ;;=3^277.30
 ;;^UTILITY(U,$J,358.3,12010,1,4,0)
 ;;=4^AMYLOIDOSIS NOS
 ;;^UTILITY(U,$J,358.3,12010,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,12011,0)
 ;;=277.31^^71^729^3
 ;;^UTILITY(U,$J,358.3,12011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12011,1,3,0)
 ;;=3^277.31
 ;;^UTILITY(U,$J,358.3,12011,1,4,0)
 ;;=4^FAM MEDITERRANEAN FEVER
 ;;^UTILITY(U,$J,358.3,12011,2)
 ;;=^189367
 ;;^UTILITY(U,$J,358.3,12012,0)
 ;;=277.39^^71^729^2
 ;;^UTILITY(U,$J,358.3,12012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12012,1,3,0)
 ;;=3^277.39
 ;;^UTILITY(U,$J,358.3,12012,1,4,0)
 ;;=4^AMYLOIDOSIS,OTHER
 ;;^UTILITY(U,$J,358.3,12012,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,12013,0)
 ;;=446.21^^71^729^4
 ;;^UTILITY(U,$J,358.3,12013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12013,1,3,0)
 ;;=3^446.21
 ;;^UTILITY(U,$J,358.3,12013,1,4,0)
 ;;=4^GOODPASTURE'S SYNDROME
 ;;^UTILITY(U,$J,358.3,12013,2)
 ;;=^52601^583.81
 ;;^UTILITY(U,$J,358.3,12014,0)
 ;;=580.0^^71^729^8
 ;;^UTILITY(U,$J,358.3,12014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12014,1,3,0)
 ;;=3^580.0
 ;;^UTILITY(U,$J,358.3,12014,1,4,0)
 ;;=4^NEPHRITIS,AC PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,12014,2)
 ;;=^270338
 ;;^UTILITY(U,$J,358.3,12015,0)
 ;;=580.4^^71^729^9
 ;;^UTILITY(U,$J,358.3,12015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12015,1,3,0)
 ;;=3^580.4
 ;;^UTILITY(U,$J,358.3,12015,1,4,0)
 ;;=4^NEPHRITIS,AC RAPIDLY PROGR
 ;;^UTILITY(U,$J,358.3,12015,2)
 ;;=^270339
 ;;^UTILITY(U,$J,358.3,12016,0)
 ;;=580.9^^71^729^7
 ;;^UTILITY(U,$J,358.3,12016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12016,1,3,0)
 ;;=3^580.9
 ;;^UTILITY(U,$J,358.3,12016,1,4,0)
 ;;=4^NEPHRITIS,AC NOS
 ;;^UTILITY(U,$J,358.3,12016,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,12017,0)
 ;;=582.0^^71^729^14
 ;;^UTILITY(U,$J,358.3,12017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12017,1,3,0)
 ;;=3^582.0
 ;;^UTILITY(U,$J,358.3,12017,1,4,0)
 ;;=4^NEPHRITIS,CHR PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,12017,2)
 ;;=^270347
 ;;^UTILITY(U,$J,358.3,12018,0)
 ;;=582.1^^71^729^12
 ;;^UTILITY(U,$J,358.3,12018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12018,1,3,0)
 ;;=3^582.1
 ;;^UTILITY(U,$J,358.3,12018,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOUS
 ;;^UTILITY(U,$J,358.3,12018,2)
 ;;=^24388
 ;;^UTILITY(U,$J,358.3,12019,0)
 ;;=582.2^^71^729^11
 ;;^UTILITY(U,$J,358.3,12019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12019,1,3,0)
 ;;=3^582.2
 ;;^UTILITY(U,$J,358.3,12019,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOPROLIF
 ;;^UTILITY(U,$J,358.3,12019,2)
 ;;=^24386
 ;;^UTILITY(U,$J,358.3,12020,0)
 ;;=582.4^^71^729^15
 ;;^UTILITY(U,$J,358.3,12020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12020,1,3,0)
 ;;=3^582.4
 ;;^UTILITY(U,$J,358.3,12020,1,4,0)
 ;;=4^NEPHRITIS,CHR RAPID PROGR
 ;;^UTILITY(U,$J,358.3,12020,2)
 ;;=^270348
 ;;^UTILITY(U,$J,358.3,12021,0)
 ;;=582.81^^71^729^10
 ;;^UTILITY(U,$J,358.3,12021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12021,1,3,0)
 ;;=3^582.81
 ;;^UTILITY(U,$J,358.3,12021,1,4,0)
 ;;=4^NEPHRITIS,CHR IN OTH DIS
 ;;^UTILITY(U,$J,358.3,12021,2)
 ;;=^270350
 ;;^UTILITY(U,$J,358.3,12022,0)
 ;;=582.9^^71^729^13
 ;;^UTILITY(U,$J,358.3,12022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12022,1,3,0)
 ;;=3^582.9
 ;;^UTILITY(U,$J,358.3,12022,1,4,0)
 ;;=4^NEPHRITIS,CHR NOS
 ;;^UTILITY(U,$J,358.3,12022,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,12023,0)
 ;;=583.81^^71^729^5
 ;;^UTILITY(U,$J,358.3,12023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12023,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,12023,1,4,0)
 ;;=4^NEPHRITIS IN OTH DIS
 ;;^UTILITY(U,$J,358.3,12023,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,12024,0)
 ;;=583.81^^71^729^16
 ;;^UTILITY(U,$J,358.3,12024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12024,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,12024,1,4,0)
 ;;=4^SECONDARY GLOMERONEPHRITIS
 ;;^UTILITY(U,$J,358.3,12024,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,12025,0)
 ;;=583.9^^71^729^6
 ;;^UTILITY(U,$J,358.3,12025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12025,1,3,0)
 ;;=3^583.9
 ;;^UTILITY(U,$J,358.3,12025,1,4,0)
 ;;=4^NEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,12025,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,12026,0)
 ;;=710.0^^71^729^17
 ;;^UTILITY(U,$J,358.3,12026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12026,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,12026,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,12026,2)
 ;;=^72159^582.81
 ;;^UTILITY(U,$J,358.3,12027,0)
 ;;=582.89^^71^730^2
 ;;^UTILITY(U,$J,358.3,12027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12027,1,3,0)
 ;;=3^582.89
 ;;^UTILITY(U,$J,358.3,12027,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,CHR
 ;;^UTILITY(U,$J,358.3,12027,2)
 ;;=^270349
 ;;^UTILITY(U,$J,358.3,12028,0)
 ;;=580.89^^71^730^1
 ;;^UTILITY(U,$J,358.3,12028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12028,1,3,0)
 ;;=3^580.89
 ;;^UTILITY(U,$J,358.3,12028,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,AC
 ;;^UTILITY(U,$J,358.3,12028,2)
 ;;=^270340
 ;;^UTILITY(U,$J,358.3,12029,0)
 ;;=583.89^^71^730^3
 ;;^UTILITY(U,$J,358.3,12029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12029,1,3,0)
 ;;=3^583.89
 ;;^UTILITY(U,$J,358.3,12029,1,4,0)
 ;;=4^NEPHROPATHY,ANALGESIC
 ;;^UTILITY(U,$J,358.3,12029,2)
 ;;=^83443
 ;;^UTILITY(U,$J,358.3,12030,0)
 ;;=042.^^71^731^1
 ;;^UTILITY(U,$J,358.3,12030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12030,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,12030,1,4,0)
 ;;=4^AIDS
 ;;^UTILITY(U,$J,358.3,12030,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,12031,0)
 ;;=581.1^^71^731^2
 ;;^UTILITY(U,$J,358.3,12031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12031,1,3,0)
 ;;=3^581.1
 ;;^UTILITY(U,$J,358.3,12031,1,4,0)
 ;;=4^NEPHRITIS EPIMEMBRANOUS (FSGS)
 ;;^UTILITY(U,$J,358.3,12031,2)
 ;;=^270344
 ;;^UTILITY(U,$J,358.3,12032,0)
 ;;=581.2^^71^731^3
 ;;^UTILITY(U,$J,358.3,12032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12032,1,3,0)
 ;;=3^581.2
 ;;^UTILITY(U,$J,358.3,12032,1,4,0)
 ;;=4^NEPHROSIS MEMBRANOPROL
 ;;^UTILITY(U,$J,358.3,12032,2)
 ;;=^270345
 ;;^UTILITY(U,$J,358.3,12033,0)
 ;;=581.3^^71^731^4
 ;;^UTILITY(U,$J,358.3,12033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12033,1,3,0)
 ;;=3^581.3
 ;;^UTILITY(U,$J,358.3,12033,1,4,0)
 ;;=4^NEPHROSIS,MINIMAL CHANGE
 ;;^UTILITY(U,$J,358.3,12033,2)
 ;;=^82320
 ;;^UTILITY(U,$J,358.3,12034,0)
 ;;=581.9^^71^731^5
 ;;^UTILITY(U,$J,358.3,12034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12034,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,12034,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,12034,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,12035,0)
 ;;=446.0^^71^731^6
 ;;^UTILITY(U,$J,358.3,12035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12035,1,3,0)
 ;;=3^446.0
 ;;^UTILITY(U,$J,358.3,12035,1,4,0)
 ;;=4^POLYARTERITIS
 ;;^UTILITY(U,$J,358.3,12035,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,12036,0)
 ;;=581.81^^71^731^7
 ;;^UTILITY(U,$J,358.3,12036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12036,1,3,0)
 ;;=3^581.81
 ;;^UTILITY(U,$J,358.3,12036,1,4,0)
 ;;=4^SECONDARY NEPHROTIC SYNDROME
 ;;^UTILITY(U,$J,358.3,12036,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,12037,0)
 ;;=710.0^^71^731^8
 ;;^UTILITY(U,$J,358.3,12037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12037,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,12037,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,12037,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,12038,0)
 ;;=596.0^^71^732^1
 ;;^UTILITY(U,$J,358.3,12038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12038,1,3,0)
 ;;=3^596.0
 ;;^UTILITY(U,$J,358.3,12038,1,4,0)
 ;;=4^BLADDER NECK OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,12038,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,12039,0)
 ;;=592.0^^71^732^2
 ;;^UTILITY(U,$J,358.3,12039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12039,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,12039,1,4,0)
 ;;=4^CALCULUS OF KIDNEY
 ;;^UTILITY(U,$J,358.3,12039,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,12040,0)
 ;;=592.1^^71^732^3
 ;;^UTILITY(U,$J,358.3,12040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12040,1,3,0)
 ;;=3^592.1
 ;;^UTILITY(U,$J,358.3,12040,1,4,0)
 ;;=4^CALCULUS OF URETER
 ;;^UTILITY(U,$J,358.3,12040,2)
 ;;=^124125
 ;;^UTILITY(U,$J,358.3,12041,0)
 ;;=591.^^71^732^4
 ;;^UTILITY(U,$J,358.3,12041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12041,1,3,0)
 ;;=3^591.
